MiNK Therapeutics, Inc. Cash and Cash Equivalents
MiNK Therapeutics, Inc. (INKT) had Cash and Cash Equivalents of $8.81 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $8.81M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $9.53M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $13.36M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $9.50M; Cash and Cash Equivalents, at Carrying Value as first filed $14.28M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $8.81M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $9.53M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $13.36M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $9.50M 10-Q · filed 2026-05-15 | $14.28M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.68M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $3.23M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $4.58M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $6.33M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $9.31M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $5.82M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.37M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $6.40M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $10.62M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $14.89M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $19.64M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $24.16M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $29.85M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $34.69M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $38.89M 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |